Title:
PHARMACEUTICAL COMPOSITION COMPRISING PYRIDOPYRIMIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
Document Type and Number:
WIPO Patent Application WO/2017/133542
Kind Code:
A1
Abstract:
The present invention discloses a pharmaceutical composition comprising a pyridopyrimidine derivative or a pharmaceutically acceptable salt thereof. Specifically, the composition comprises 6-acetyl-8- cyclopentyl-5-methyl-2-{[5-(piperidin-4-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one or a pharmacologically acceptable salt thereof, and a disintegrant. The disintegrant is a disintegrant with no metallic element. The composition dissolves rapidly. The preparation process of the pharmaceutical composition of the present invention is simple and more suitable for industrial-scale production.
Inventors:
LU YUN (CN)
ZHANG XINHUA (CN)
DING HUAN (CN)
ZHANG DAIMEI (CN)
ZHANG XINHUA (CN)
DING HUAN (CN)
ZHANG DAIMEI (CN)
Application Number:
PCT/CN2017/072213
Publication Date:
August 10, 2017
Filing Date:
January 23, 2017
Export Citation:
Assignee:
JIANGSU HENGRUI MEDICINE CO (CN)
International Classes:
A61K31/519; A61K9/20; A61K47/32; A61K47/38; A61P35/00; A61P35/04
Domestic Patent References:
| WO2016169422A1 | 2016-10-27 | |||
| WO2014183520A1 | 2014-11-20 |
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (CN)
Download PDF:
Previous Patent: METHOD AND APPARATUS FOR INFORMATION RECOMMENDATION
Next Patent: NFC ANTENNA FOR WEARABLE APPLICATION
Next Patent: NFC ANTENNA FOR WEARABLE APPLICATION